Table 1.
Demographic and clinical characteristics of patients newly diagnosed with HIV treated at OAHCC, January 1, 2016–December 31, 2018
| All patients, n (%) | Rapid-ART group, n (%) | Non-Rapid ART group, n (%) | P-value for comparison of rapid versus non-rapid groups (α = 0.05) | |
|---|---|---|---|---|
| Number | 63 | 16 | 47 | |
| Age (in years) | ||||
| Median Age (range) | 27 (20–61) | 29.5 (21–53) | 27 (20–61) | 0.38 |
| Sex (gender when available) | 0.50 | |||
| Male | 53 (84%) | 14 (88%) | 39 (83%) | |
| Female | 8 (13%) | 2 (13%) | 6 (13%) | |
| Transgender female | 2 (3%) | 0 (0) | 2 (4%) | |
| Race/ethnicity | 0.32 | |||
| Black/African American | 57 (91%) | 16 (100%) | 41 (87%) | |
| Hispanic/latinx | 3 (4.8%) | 0 (0) | 3 (6%) | |
| White | 3 (4.8%) | 0 (0) | 3 (6%) | |
| Sexual orientation | 0.35 | |||
| Gay/homosexual | 35 (56%) | 11 (69%) | 24 (51%) | |
| Heterosexual | 16 (25%) | 2 (13%) | 14 (30%) | |
| Bisexual | 12 (19%) | 3 (19%) | 9 (19%) | |
| Insurance | 0.45 | |||
| Uninsured | 36 (57%) | 8 (50%) | 28 (60%) | |
| Commercial | 20 (32%) | 7 (44%) | 13 (28%) | |
| Government Ins. (medicaid/medicare) | 7 (11%) | 1 (6%) | 6 (12%) | |
| Substance use | 0.84 | |||
| Marijuana | 14 (22%) | 3 (18%) | 11 (65%) | |
| Other (cocaine, opioids, etc.) | 3 (5%) | 1 (5%) | 2 (12%) | |
| Baseline CD4+, HIV RNA (mean, ± SD) | ||||
| CD4+ T cell count (cells/μl) | 446 (± 290.25) | 603 (± 323.74) | 393 (± 260.64) | 0.009 |
| HIV RNA (copies/mL) | 49,768 (130–10 million) | 22,800 (500–10 million) | 60,199 (130–3.8 million) | 0.076 |